Journals / Diagnostic and Interventional Radiology / 2022 / Cilt: 28 - Sayı: 1

Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings

Pages
12–20
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION The mean ADC ratio of the tumor to normal prostate showed the highest accuracy and AUC in differentiating GS 3 + 4 PCa and PCa with a higher GS across different MRI acquisition settings; however, the performance of different ADC and DWI metrics did not differ significantly

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE In this study, we assessed the performance of apparent diffusion coefficient (ADC) and diffusion-weighted imaging (DWI) metrics and their ratios across different magnetic resonance imaging (MRI) acquisition settings, with or without an endorectal coil (ERC), for the evaluation of prostate cancer (PCa) aggressiveness using whole-mount specimens as a reference.
📊
Key Findings & Data:METHODS We retrospectively reviewed the data of pCa patients with a Gleason score (GS) of 3 + 4 or higher who underwent prostate MRI using a 3T unit at our institution.
💡
Conclusion & Impact:CONCLUSION The mean ADC ratio of the tumor to normal prostate showed the highest accuracy and AUC in differentiating GS 3 + 4 PCa and PCa with a higher GS across different MRI acquisition settings; however, the performance of different ADC and DWI metrics did not differ significantly
🔬Design:Review & Systematic Survey
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

PURPOSE In this study, we assessed the performance of apparent diffusion coefficient (ADC) and diffusion-weighted imaging (DWI) metrics and their ratios across different magnetic resonance imaging (MRI) acquisition settings, with or without an endorectal coil (ERC), for the evaluation of prostate cancer (PCa) aggressiveness using whole-mount specimens as a reference. METHODS We retrospectively reviewed the data of pCa patients with a Gleason score (GS) of 3 + 4 or higher who underwent prostate MRI using a 3T unit at our institution. They were divided into two groups based on the use of ERC for MRI acquisition, and patients who underwent prostate MRI with an ERC constituted the ERC (n = 55) data set, while the remaining patients accounted for the non-ERC data set (n = 41). DWI was performed with b-values of 50, 500, 1000, and 1400 s/mm2 , and ADC maps were automatically calculated. Additionally, computed DWI (cDWI) was performed with a b-value of 2000 s/mm2 . Six ADC and two cDWI parameters were evaluated. In the ERC data set, receiver operating characteristic curves were plotted for each metric to determine the best cutoff threshold values for differentiating GS 3 + 4 PCa from that with a higher GS. The performance of these cutoff values was assessed in non-ERC data set. The diagnostic accuracies and area under the curves (AUCs) of the metrics were compared using Fisher exact test and De Long method, respectively. RESULTS Among all metrics, the mean ADC ratio of the tumor to normal prostate (ADCmean-ratio) yielded the highest AUC, 0.84, for differentiating GS 3 + 4 PCa from that with a higher GS. The best threshold cutoff values of ADCmean-ratio (≤0.51) for discriminating GS 3 + 4 PCa from that with a higher GS correctly classified 48 of 55 patients with an accuracy of 87.27%. However, there was no significant difference between the metrics in terms of accuracy and AUC (P = .163 and P = .214). Similarly, in the non-ERC data set, the ADCmean-ratio provided the highest diagnostic accuracy (82.92%) by classifying 34 of 41 patients. However, Fisher exact test yielded no significant difference between DWI and ADC metrics in terms of diagnostic accuracy in nonERC data (P = .561). CONCLUSION The mean ADC ratio of the tumor to normal prostate showed the highest accuracy and AUC in differentiating GS 3 + 4 PCa and PCa with a higher GS across different MRI acquisition settings; however, the performance of different ADC and DWI metrics did not differ significantly

🔖

Cite This Article

KARAARSLAN, E., ALIŞ, D., SAĞLICAN, Y., KURAL, A. R., KUŞ, A. A., KARAARSLAN, U. C., ARGUN, Ö. B. (2022). Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings. Diagnostic and Interventional Radiology, Cilt: 28 - Sayı: 1, 12–20. https://ajindex.com/articles/487234

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate imaging reporting and data system Version 2.1: 2019 Update of Prostate imaging reporting and data system Version 2. Eur Urol. 2019
  2. 76(3):340-351. [Crossref] 2. Verma S, Rajesh A, Morales H, et al. Assessment of aggressiveness of prostate cancer: Correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR. 2011
  3. 196(2):374-381. [Crossref] 3. Hambrock T, Somford DM, Huisman HJ, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology. 2011
  4. 259(2):453-461. [Crossref] 4. Vargas HA, Akin O, Franiel T, et al. Diffusionweighted endorectal MR imaging at 3 T for prostate cancer: Tumor detection and assessment of aggressiveness. Radiology. 2011
  5. 259(3):775-784. [Crossref] 5. Caster JM, Falchook AD, Hendrix LH, Chen RC. Risk of pathologic upgrading or locally advanced disease in early prostate cancer patients based on biopsy Gleason score and PSA: A population-- based study of modern patients. Int J Radiat Oncol Biol Phys. 2015
  6. 92(2):244. [Crossref] 6. Lebovici A, Sfrangeu SA, Feier D, et al. Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness. BMC Med Imaging. 2014
  7. [Crossref] 7. Boesen L, Chabanova E, Logager V, Balslev I, Thomsen HS. Apparent diffusion coefficient ratio correlates significantly with prostate cancer Gleason score at final pathology. J Magn Reson Imaging. 2015
  8. 42(2):446-453. [Crossref] 8. Barrett T, Priest AN, Lawrence EM, et al. Ratio of tumor to normal prostate tissue apparent diffusion coefficient as a method for quantifying DWI of the prostate. AJR. 2015
  9. 205(6):585-593. [Crossref] 9. Itatani R, Namimoto T, Yoshimura A, et al. Clinical utility of the normalized apparent diffusion coefficient for preoperative evaluation of the aggressiveness of prostate cancer. Jpn J Radiol. 2014
  10. 32(12):685-691. [Crossref] 10. Woo S, Kim SY, Cho JY, Kim SH. Preoperative evaluation of prostate cancer aggressiveness: Using ADC and ADC Ratio in determining Gleason score. AJR. 2016
  11. 207(1):114-120. [Crossref] 11. Rosenkrantz AB, Khalef V, Xu W, Babb JS, Taneja SS, Doshi AM. Does normalisation improve the diagnostic performance of apparent diffusion coefficient values for prostate cancer assessment? A blinded independent-observer evaluation. Clin Radiol. 2015
  12. 70 (9):1032-1037. [Crossref] 12. De Cobelli F, Ravelli